Jan Budczies
Statistics and Probability · 2010–2020
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 7 citations into it
Whom Jan Budczies trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jan Budczies overall
Papers from Jan Budczies's perspective
Ordered by how strongly the researchers Jan Budczies trusts endorse each paper. Same corpus, a different order for every researcher.
- Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction (PLoS ONE)
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (New England Journal of Medicine)
- FlexMix: A general framework for finite mixture models and latent class regression in R
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. (Journal of Oncology Practice)
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements (Nature Biotechnology)
- Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. (Journal of Clinical Oncology)
- Evaluation of gene expression measurements from commercial microarray platforms. (Nucleic Acids Research)
- affy - analysis of Affymetrix GeneChip data at the probe level (Bioinform.)
- Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. (Journal of Clinical Oncology)
- Reliability and reproducibility issues in DNA microarray measurements. (Trends in Genetics)
Their papers
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients (2010) — 2,609 citations
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer (2013) — 1,628 citations
- Tumor Mutational Burden (TMB) as a Predictive Biomarker in Solid Tumors (2020) — 628 citations
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. (2018) — 1,800 citations
- The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. (2012) — 655 citations
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization (2012) — 1,152 citations
- Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. (2010) — 1,620 citations